Is your drug safe enough to enter the clinic?
Event date 14 January 2020 16:30 – 18:00
Location Innovation Hub, Dag Hammarskjöld väg 38, 751 83 Uppsala
We, together with UppsalaBio, invites you to listen to the panel debate where Sara Mangsbo, researcher and entrepreneur of the year will moderate the insightful discussion.
Hear about the latest optimal approaches to managing risk and learn from the experts how to build value in early clinical development, as well as how to navigate the evolving regulatory space.
Lecturer: Sara Mangsbo (Moderator)
Panelists: Bengt Dahlström (CSO, Clinical Trial Consultants), Justyna Leja-Jarblad (COO Immuneed) and Marie Gårdmark (CEO at RegSmart)
About the companies:
Immuneed was founded in 2014 and initially focused on the development of a novel immunotherapy for cancer. In 2018, the vaccine project was acquired by the Norwegian pharmaceutical company Ultimovacs. Today they are fully focused on developing Immuneed’s platform and associated services, to address important questions related to the safety and function of biopharmaceuticals.
CTC’s mission is to facilitate clinical and translational research by providing their customers with cost-effective advice, conduct and reporting of clinical trials. They have four different units: Clinical Research Units, Clinical Operations, Pharmacovigilance and Biometrics, all supported by independent quality assurance management.
Regsmart Life Science is a regulatory consultancy firm that helps navigation in a complex and evolving regulatory landscape. With a long regulatory experience, they provide fit for purpose advice and support in relation to European and US regulation.
Be a part of the life science scene in Uppsala!
When: 14 January, 2020. 16.30-18.00
Where: Innovation Hub, Dag Hammarskjöld väg 38, 751 83 Uppsala
We will serve wraps and coffee!
CTC Clinical Trial Consultants AB is a full-service CRO with focus on clinical conduct. Our mission is to facilitate clinical and translational research by providing our customers with cost-effective advice, conduct and reporting of clinical trials. We have four different departments: Clinical Research Units, Clinical Operations, Pharmacovigilance and Biometrics, all supported by independent quality assurance management.
Our head office and Phase 1 units are located in Uppsala comprising 28 beds of which 12 are hospital beds in a first-in-human approved research unit whereas our two professional sites for multicenter studies (SMOs) are found in Uppsala and Linköping. We have our own subject database for recruitment of both healthy volunteers and special patient populations.
CTC was founded in 2011 and has successfully conducted over 250 industry sponsored clinical trials for start-up companies as well as for international pharmaceutical companies and CROs. Our track record includes first-in-human, food effect, drug interaction, bioequivalence, bioavaliability and biosimilar studies, new drug delivery systems, medical device, PET/MR, QT and Phase IIa studies.